These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3332704)

  • 1. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
    Debbia E; Soro O
    Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
    Fazli SA; Aksebzeci T
    Mikrobiyol Bul; 1989 Oct; 23(4):356-60. PubMed ID: 2488944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of resistance to cephalosporins.
    Atkinson BA
    Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH; Brus-Weijer L; Michel MF
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
    Lee YH; Hussain ZA; Choong FP
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of gram-negative bacilli to aminoglycosides].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ceftizoxime: in vitro evaluation].
    Fernández AJ; de Mier CA; Herran IL; Marcenac F
    Medicina (B Aires); 1989; 49(5):533-6. PubMed ID: 2487423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
    Arai T
    Jpn J Antibiot; 1986 May; 39(5):1237-40. PubMed ID: 3463774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of third-generation cephalosporins into human peritoneal tissue.
    Berger SA; Dan M; Serour F; Gorea A; Levenberg A; Krispin M
    Chemotherapy; 1989; 35(5):326-9. PubMed ID: 2676403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
    Jones RN; Pfaller MA; Allen SD; Gerlach EH; Fuchs PC; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(4):361-4. PubMed ID: 1889187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.